Apr 24 |
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
|
Apr 21 |
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
|
Apr 9 |
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
|
Apr 9 |
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results
|
Apr 8 |
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
|
Apr 5 |
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
|
Mar 29 |
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
|
Mar 26 |
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
|
Mar 25 |
Iovance Biotherapeutics: Initial Amtagvi Launch In Focus
|
Mar 23 |
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
|